Inhibition of PDE10A with MP-10 and TP-10 reduced cytokine release and cell death, suggesting potential therapeutic benefits for modulating inflammation and improving recovery in conditions like traumatic nerve injury and sepsis. Here, PDE10A is linked to Sepsis.